Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy.

MLA

Grau-Vorster, Marta, et al. “Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy.” Frontiers in Immunology, vol. 11, Feb. 2020, p. 271. EBSCOhost, https://doi.org/10.3389/fimmu.2020.00271.

APA

Grau-Vorster, M., López-Montañés, M., Cantó, E., Vives, J., Oliver-Vila, I., Barba, P., Querol, S., & Rudilla, F. (2020). Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy. Frontiers in Immunology, 11, 271. https://doi.org/10.3389/fimmu.2020.00271

Chicago

Grau-Vorster, Marta, María López-Montañés, Ester Cantó, Joaquim Vives, Irene Oliver-Vila, Pere Barba, Sergi Querol, and Francesc Rudilla. 2020. “Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy.” Frontiers in Immunology 11 (February): 271. doi:10.3389/fimmu.2020.00271.